Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer.
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 12/1/2013, Vol. 31 Issue 34, p4297-4305, 14p
- Subject
- Language
- ISSN
- 0732183X